HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 276, Issue 28, 26499-26508, July 13, 2001

This Article Abstract Full Text (PDF) All Versions of this Article: 276/28/26499    most recent M010357200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hartness, M. E. Articles by Kemp, P. J. Search for Related Content PubMed PubMed Citation Articles by Hartness, M. E. Articles by Kemp, P. J. Social Bookmarking                      What's this?

Combined Antisense and Pharmacological Approaches Implicate hTASK as an Airway O₂ Sensing K⁺ Channel^*

Matthew E. Hartness, Anthony Lewis, Gavin J. Searle, Ita O'Kelly^§, Chris Peers^§, and Paul J. Kemp^¶

From the  School of Biomedical Sciences, Worsley Medical and Dental Building and the ^§ Institute for Cardiovascular Research, University of Leeds, Leeds LS2 9JT, United Kingdom

Received for publication, November 15, 2000, and in revised form, May 8, 2001

	ABSTRACT

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

Neuroepithelial bodies act as airway oxygen sensors. The lung carcinoma line H146 is an established model for neuroepithelial body cells. Although O₂ sensing in both cells is via NADPH oxidase H₂O₂/free radical production and acute hypoxia promotes K⁺ channel closure and cell depolarization, the identity of the K⁺ channel is still controversial. However, recent data point toward the involvement of a member of the tandem P domain family of K⁺ channels. Reverse transcription-polymerase chain reaction screening indicates that all known channels other than hTWIK1 and hTRAAK are expressed in H146 cells. Our detailed pharmacological characterization of the O₂-sensitive K⁺ current described herein is compatible with the involvement of hTASK1 or hTASK3 (pH dependence, tetraethylammonium and dithiothreitol insensitivity, blockade by arachidonic acid, and halothane activation). Furthermore, we have used antisense oligodeoxynucleotides directed against hTASK1 and hTASK3 to suppress almost completely the hTASK1 protein and show that these cells no longer respond to acute hypoxia; this behavior was not mirrored in liposome-only or missense-treated cells. Finally, we have used Zn²⁺ treatment as a maneuver able to discriminate between these two homologues of hTASK and show that the most likely candidate channel for O₂ sensing in these cells is hTASK3.

	INTRODUCTION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

Oxygen-sensitive K⁺ channels are found in numerous tissues, where they regulate cellular function in the face of reduced or increased pO₂¹ (1, 2). One such tissue is the airway of the lung, where neuroepithelial bodies (NEBs) are believed to be involved in optimizing ventilation-perfusion matching via both local vasoconstriction and ascending input to medullary respiratory centers (3). At the cellular level, NEBs have been shown to express O₂-sensitive K⁺ channels (4), which are functionally coupled to a membrane-associated O₂ sensor, the multicomponent enzyme NADPH oxidase (5). Although details of the mechanism responsible for transducing reduced pO₂ into the full physiological response of hypoxia-evoked transmitter release are steadily emerging, the molecular identity of the O₂-sensitive K⁺ channel responsible for hypoxia-induced cell depolarization is still uncertain.

To study this signal transduction pathway more completely at the molecular level, we have recently established an immortalized cellular model for NEB cells (6-8). The small cell lung carcinoma line H146 is derived from the same precursor pool as NEB cells (9) and shares numerous characteristics, including an O₂-sensitive K⁺ channel (linked to NADPH oxidase (6, 10)) and serotonin-containing secretory granules (3), which are released in response to hypoxia (11).

Based on in situ hybridization and Northern blot analyses, it has been suggested that in native neonatal rabbit NEB cells, Kv3.3 may be involved in O₂ transduction (10). This channel has also been identified in small cell lung carcinoma cell lines (including H146) at the mRNA level. Kv3.3 expressed in Xenopus oocytes has been shown to be sensitive to a downstream product of NADPH oxidase activity, H₂O₂ (10). However, this channel has not been shown to influence resting membrane potential, and other cell types (e.g. carotid body glomus cells) are known to possess multiple O₂-sensitive K⁺ channels (12, 13). Therefore, although Kv3.3 may indeed be an O₂-sensitive K⁺ channel, there are a number of lines of evidence (physiological, molecular, pharmacological and comparative) to suggest that hypoxia-evoked depolarization, and hence the physiologically more important response, may be underpinned by closure of a member of the tandem P domain K⁺ channel family (K_2P), namely the acid-sensitive TASK gene product. These lines of evidence include 1) our earlier observation of differential amplification of mRNA encoding hTASK1 (over hTWIK1) from H146 cells by RT-PCR (7); 2) the observation that rTASK1 mRNA has been detected by in situ hybridization and implicated in O₂ signal transduction in another important O₂ sensing tissue, the carotid body (12); 3) hypoxia-evoked cell depolarization in H146 cells is almost insensitive to the broad spectrum K⁺ channel blocker tetraethylammonium (TEA) at concentrations well above those documented to inhibit most voltage-sensitive K⁺ channels, including Kv3.3 (8); and 4) O₂-sensitive K⁺ currents of H146 cells (as well as hypoxia-evoked cell depolarization in this cell model), isolated NEB cells, and NEB cells in lung slice are 4-aminopyridine-insensitive but completely blocked by quinidine (7). Because K_2P channels are known to be active at (and so be major determinants of) resting membrane potential (14), they are attractive candidate channels that could link to NADPH oxidase in both NEBs (5) and small cell lung carcinoma cells (6). However, our previous suggestion that hTASK was the O₂-sensitive channel in H146 cells can be criticized on the basis of our initial failure to demonstrate pH sensitivity of the K⁺ current (7). In our initial studies, we conducted all pH dependence experiments in the presence of Cd²⁺ in order to remove any Ca²⁺-activated K⁺ current contamination from the whole cell conductance recordings. However, interpretation of these data is confounded by the suggestion that there is competition between Cd²⁺ and H⁺ when binding to a number of different channel types, including Cl (15) and K⁺ channels (16). To investigate this possibility in H146 cells, we have revisited the pH sensitivity of their whole-cell currents and demonstrated that in the absence of external Cd²⁺, the O₂-sensitive K⁺ current is indeed depressed by lowering pH, consistent with TASK contributing significantly to O₂ sensing in these cells.

To date, many investigations have concentrated on cloning and characterizing tandem P-domain channels in recombinant systems (see e.g. Refs. 14 and 17-20), and limited headway (12, 21) has been made in demonstrating directly the involvement of this emerging class of ion channels in cell physiological function of tissues or cells. To this end, and to test directly the hypothesis that hTASK is an O₂-sensitive K⁺ channel in this model cell line (and, by inference, in NEB cells), we have used RT-PCR to screen for K_2P channel mRNA and employed antisense oligodeoxynucleotides as a method by which to reduce/block hTASK transcription/translation. These data, in combination with a sequential pharmacological approach using compounds that can discriminate between different members of the K_2P class of channels specifically, and other K⁺ channels in general, indicate hTASK3 is the O₂-sensitive K⁺ channel in this model for airway chemoreceptors and represents a significant advance in our understanding of the molecular basis of ion channel O₂ sensing.

	EXPERIMENTAL PROCEDURES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

Cell Culture-- The small cell lung carcinoma cell line, H146, was purchased from American Tissue Type Cell Collection (Manassas, VA) and was maintained in culture using the same regimen as previously described (6).

RT-PCR Screening for mRNA Encoding Human K_2P Channels-- Total RNA was extracted from pelleted H146 cells using the RNeasy Mini Kit (Qiagen, Crawley, West Sussex, United Kingdom) and treated with RQ-1 RNase-free DNase (1 units·µg¹ RNA; Promega, Southampton, Hampshire, United Kingdom) to remove genomic DNA contamination, before reextraction using the RNeasy mini kit. The yield, purity, and integrity of the RNA was verified by spectrophotometry at 260/280 nm, followed by electrophoresis on 1% agarose, and high quality RNA was then stored in aqueous solution at 80 °C. Reverse transcription was performed on 1-µg aliquots of RNA using the reverse transcription system A3500 (Promega), comprising avian myeloblastosis virus reverse transcriptase and oligo(dT) (15) primers (42 °C, 15 min). The resulting cDNA was amplified by PCR using a panel of oligonucleotide primer pairs (described in Fig. 2B) designed against the published sequences of the human homologues of TASK1 (GenBank^TM accession number AF006823), TASK2 (AF084830), TASK3 (AC007869), TREK1 (AF004711), TREK2 (XM012342), TWIK1 (U90065), TWIK2 (AF117708), and TRAAK (XM006543). Amplification of 1 µl of cDNA (equivalent to 160 ng of reverse-transcribed RNA) was performed using a Hybaid Express thermal cycler (Ashford, Middlesex, United Kingdom), in a volume of 50 µl, containing 1 µl of Advantage-GC2 polymerase (Promega), under optimized conditions. The hot-start PCR protocol was 94 °C for 1 min, X °C for 1 min, and 72 °C for 1 min for 35 cycles with a final extension period of 10 min at 72 °C. Optimized anealling temperatures (X °C) were gene-specific and are shown in Fig. 2B. Products were separated on 2% agarose gels and visualized with ethidium bromide/UV transillumination. Sequencing of all amplicons was carried out by dye terminator PCR with an ABI PRISM automated sequencer (School of Biology, University of Leeds, United Kingdom) and allowed verification of the identity of each PCR product.

Antisense and Missense Oligodeoxynucleotide Design and Application-- H146 cells were transfected with either 1) LipofectAMINE only, 2) 5'-FITC-labeled, phosphothioate-modified antisense (sequence 5'-cgttctgccgcttcatcg-3'; Genosys Biotechnologies, Pampisford, Cambridge, United Kingdom) directed across the translation start site of human TASK1 and TASK3, or 3) 5'-FITC-labeled, phosphothioate-modified missense (sequence 5'-gccgtctatcttcgcgct-3'; Genosys Biotechnologies), which consisted of the same bases as employed in the antisense probe but in "random" order (see Fig. 2C). We confirmed, by PCR and sequencing, that the first 115 base pairs of H146 cell hTASK1 and the first 125 base pairs of hTASK3 open reading frames were 100% identical to the published sequences. This allowed the design of an antisense deoxynucleotide probe that spanned the atg start codon of both sequences (nucleotides 123-126 of TASK1 and 94-97 of TASK3), a region of the gene known to be a useful target functionally for antisense maneuvers in other systems (see Ref. 22 for a review of technical considerations). TASK1 and TASK3 exhibit high sequence identity that made design of an antisense probe specific for each of these genes impossible. Therefore, the probe that we employed in this study did not distinguish between TASK1 and TASK3; thus, a functional approach was combined with this molecular abrogation technique for final channel identification. The missense sequence did not recognize any known sequences available in GenBank^TM.

Cells were seeded in six-well plates at a density of 2 × 10⁶ cells/well in 0.8 ml of serum-free RPMI 1640 medium (Life Technologies, Inc.). The oligodeoxynucleotides were diluted in 0.1 ml of serum-free RPMI 1640 medium and mixed with 0.1 ml of 6% (v/v) LipofectAMINE (Life Technologies, Inc.) in serum-free RPMI 1640 medium. The resulting oligodeoxynucleotide and cationic lipid mixture was incubated at room temperature for 30 min to allow formation of DNA-liposome complexes, which were then added (0.2 ml) to the cell suspension, mixed gently, and incubated in a humidified atmosphere of 5%CO₂/95% air at 37 °C for 4 h. Following incubation, 4 ml of complete RPMI 1640 medium (8) was added to each well. Cells were then cultured as normal for up to 5 days. The concentrations and time course of transfection were followed by measuring cellular/nuclear FITC fluorescence incorporation and were shown to be optimal at 1 µM and 4-5 days, respectively (data not shown).

Four to 5 days after lipofection, H146 cells (approximately 5 × 10⁵ cells) were cytospun onto glass poly-L-lysine-coated microscope slides for 5 min at 1200 rpm. Cells were heat-fixed by placing the slides on a hot plate for 10 s and then fixed in 10% neutral-buffered formalin for 5 min at 37 °C. The remaining procedures were carried out at room temperature. Cells were permeabilized by incubation with 0.5% Triton X-100 in PBS for 15 min, refixed in 10% formalin for 5 min, washed in PBS for 10 min, and then incubated with blocking solution (10% v/v fetal calf serum, 0.1% (w/v) bovine serum albumin and 0.01% (w/v) NaN₃ in PBS) for 1 h. Cells were then incubated overnight in 1:500 dilution of rabbit anti-hTASK1 antibody (Alomone Labs, Jerusalem, Israel) in blocking solution. Following the antibody incubation, cells were washed three times in PBS and incubated in TRITC-labeled anti-rabbit antiserum for 3 h. Finally, cells were washed an additional three times in PBS prior to mounting and viewing. Specificity of immunoreactivity was confirmed by an antigen preadsorption step using the peptide to which the antibody was originally raised. The preadsorption step employed 1.2 µg of peptide per 1 ml of diluted antibody and was carried out for 1 h at room temperature. TASK3 antibodies are not commercially available.

Electrophysiology-- Unless stated otherwise, all chemicals for whole-cell patch-clamp were of the highest grade available and were purchased from Sigma. Pipette solution was K⁺-rich and contained 10 mM NaCl, 117 mM KCl, 2 mM MgSO₄, 10 mM HEPES, 11 mM EGTA, 1 mM CaCl₂, 2 mM Na₂ATP, pH 7.2, with KOH; free [Ca²⁺] = 27 nM. Bath solution was Na⁺-rich and contained 135 mM NaCl, 5 mM KCl, 1.2 mM MgCl₂, 5 mM HEPES, 2.5 mM CaCl₂, 10 mM D-glucose, pH 7.4, with NaOH. In the pH dependence experiments, solutions were brought to the appropriate pH (6.0 or 7.4) using NaOH, and the bath electrode was embedded in a 3 M KCl/3% agarose bridge in order to minimize junction potentials; these were routinely measured and never exceeded 0.3 mV for the maneuvers presented here. All tubing was gas-impermeant (Tygon tubing, BDH, Atherstone, Berkshire, United Kingdom). Normoxic solutions were equilibrated with room air. Solutions were made hypoxic, where appropriate, by bubbling with N₂ (g) for at least 20 min prior to perfusion of cells. This procedure produced no shift in pH. Solution flow rate was approximately 5-7 ml·min¹. pO₂ was measured (at the cell) using a polarized (-800 mV), calibrated carbon fiber electrode (23); for the experiments reported herein, the pO₂ values were 150 (normoxia) and 15-25 (hypoxia) mm Hg. Cells were allowed to adhere at 37 °C for at least 1 h to poly-L-lysine-coated glass coverslips before being placed in a perfusion chamber mounted on the stage of either a Nikon TMS or a Oympus CK40 inverted microscope. All experiments were carried out at 22 ± 1 °C. Patch pipettes were manufactured from standard-walled borosilicate glass capillary tubing (Clarke Electromedical Instruments, Reading, Berkshire, United Kingdom) on a two-stage Narishige PP-83 pipette puller (Narishige Scientific Instrument Laboratory, Kasuya, Tokyo, Japan), were heat-polished on a Narishige microforge, and had measured tip resistances of 5-8 M (when filled with K⁺-rich pipette solution).

Resistive feedback voltage-clamp was achieved using an Axopatch 200 A amplifier (Axon Instruments, Foster City, CA). Voltage protocols were generated and currents were recorded using pClamp 6.0.5 or pClamp 8 software employing Digidata 1200 or 1310 A/D converters (Axon Instruments). Data were filtered (4-pole Bessel) at 1 kHz and digitized at 5 kHz. Following successful transition to the whole-cell recording mode (24), capacitance transients were compensated for and measured. To evoke ionic currents in H146 cells, a ramp voltage protocol was used (Vh = -70 mV, 0.1 Hz) as shown in Fig. 1A. The magnitude of the steady-state outward currents was measured from the 0 mV step, and current-voltage relationships were constructed from the ramp. Statistical comparisons were made using the paired or unpaired Student's t test, as appropriate, with p < 0.05 being considered significant.

	RESULTS

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

Hypoxia-sensitive Currents: Effects of TEA-- Fig. 1A shows exemplar currents elicited in voltage-clamped H146 cells during the ramp voltage protocol (shown below) before and during reduction in bath pO₂ from 150 mm Hg to between 15 and 25 mm Hg. This response is consistent with our earlier observations of hypoxic K⁺ current suppression in this cell line (6-8). Sensitivity to blockade of currents by the broad spectrum K⁺ channel inhibitor, TEA, is a maneuver capable of discriminating between specific K⁺ channels. For instance, members of the shaw K⁺ channel family (which includes Kv3.3) are highly sensitive to the actions of TEA and characteristically are blocked maximally by 1 mM (25, 26), whereas TASK channels are essentially unaffected at this concentration (14, 27-29). We have previously shown that hypoxic depolarization in current-clamped H146 cells is unaffected by 10 mM TEA (8) and extend this observation to cells under voltage-clamp. 1 mM TEA caused 30.9 ± 7.2% (n = 10) inhibition of the total K⁺ current (consistent with the concentration-response data that we have previously reported (8)). In the continuing presence of 1 mM TEA, hypoxic depression of the K⁺ current was not significantly different from that in the absence of inhibitor (Fig. 1, A and B). This is quantified in the correlation plot of Fig. 1C, where the mean hypoxia-sensitive currents were 20.1 ± 5.8 pA in control solution and 15.9 ± 5.0 pA in 1 mM TEA (p > 0.15, n = 10). This observation essentially discounts the possibility that the TEA-sensitive Kv3.3 is a significant O₂-sensitive K⁺ channel under these experimental circumstances in this cell line. Relative insensitivity to TEA (shown here) and 4-aminopyridine (shown in Ref. 7), significant blockade by quinidine (also shown in Ref. 7) and activity at resting membrane potential (shown in Ref. 8) are all hallmarks of K_2P channels; therefore, before further characterization of the current was attempted, RT-PCR screening for expression of mRNAs encoding all human K_2P channels thus far cloned (with the exception of very recently identified TASK4 (29), TASK5 KT3.3 (accession numbers AF336342 and AF257081, respectively) and THIK (30)) was conducted.

View larger version (17K): [in this window] [in a new window]   Fig. 1.   Tetraethylammonium does not prevent hypoxic inhibition of K+ currents in H146 cells. A, exemplar ramp-current traces recorded in the same cell under normoxic (~150 mm Hg) and hypoxic (15-25 mm Hg) conditions in the absence and presence of 1 mM TEA, as indicated to the right of the records. Shown below the current records is the voltage protocol that was used to evoke these currents. Holding potential, -70 mV; ramp from -100 to +60 mV over 1000 ms. The protocol was repeated at 0.1 Hz. B, exemplar time series plot in a cell under normoxic (~150 mm Hg) and hypoxic (15-25 mm Hg) conditions in the absence and presence of 1 mM TEA. Each point represents the current amplitude measured at 0 mV (taken from consecutive ramp depolarizations at 0.1 Hz and the conditions were altered as indicated by the horizontal bars). C, a plot showing the correlation between the magnitude of the hypoxic response in the absence (x axis) and presence (y axis) of 1 mM TEA. Each data point (solid circles) was taken from paired experiments exemplified in B. The dotted lines indicate the no effect and 20% inhibition levels; the latter represents the mean effect (solid square, with S.E. bars, taken from the 10 cells studied).

K_2P Channel mRNA Expression in H146 Cells-- Employing primer pairs (Fig. 2B) directed against the published sequences of human K_2P channels (TWIK1 and 2, TASK1, 2 and 3, TREK1 and 2, and TRAAK), only hTWIK1 and hTRAAK were not amplified from RQ1-treated, reverse-transcribed H146 cell mRNA (Fig. 2A). This confirms our earlier observation of hTASK1 expression and extends the number of amplifiable K_2P channels in this cell line to six. Verification of the PCR protocols for TRAAK and TWIK1 was demonstrated by the positive control lanes using uncleaned (therefore, genomic DNA- contaminated) reverse-transcribed mRNA (see Fig. 2A, TWIK1_genomic and TRAAK_genomic). All products were confirmed by sequencing.

View larger version (51K): [in this window] [in a new window]   Fig. 2.   RT-PCR screening for tandem P-domain K+ channel mRNA in H146 cells. A, 2% agarose gel showing products amplified from reverse-transcribed H146 mRNA employing the specific primer pairs complimentary to the K+ channels indicated above each lane. Also shown is a reaction in which mRNA was not reverse-transcribed (No RT) and three DNA ladders running at the base pair numbers indicated to the right. For TWIK1 and TRAAK, reactions employing genomic DNA are also shown, as a positive control for the efficiency of those reactions. The forward and reverse primer sequences employed to amplify each specific channel mRNA, the optimized annealing temperature (in °C), and the expected product size for each reaction are shown in B. C, aligned sequences spanning the ATG start codons of all the K+ channels screened in A. The shaded areas indicate base identity to hTASK1. Also shown are the antisense and missense sequences employed in this study. Note that hTASK1 and hTASK3 show remarkably high identity over this region.

Halothane, Arachidonic Acid, and DTT as Tools for Discriminating between K_2P Channel Members-- To date, two members of the K_2P channels (TREK and TASK) have been shown to be activated by volatile anesthetics (31) and such activation may be a hallmark response of this channel family. Fig. 3A shows that during exposure of cells to hypoxia, 1 mM halothane was able to rescue the K⁺ currents from hypoxic inhibition (n = 7 cells), albeit transiently. The time course of current enhancement by halothane is reminiscent of the effect of another potent activator of K⁺ currents in H146 cells, namely H₂O₂ (6). In order to refine the evidence for involvement of specific K_2P channels, we employed two further pharmacological maneuvers. First, the effects of arachidonic acid were investigated. Arachidonic acid stimulates TREK1, TREK2, TASK2, and TRAAK; is without effect on TWIK1; and inhibits TASK1 and TASK3 (see Ref. 32 for a recent review). The data presented in Fig. 3B show clearly that bath application of 20 µM arachidonic acid causes profound whole-cell current inhibition (of 59.9 ± 7.5%, n = 6) and completely abolishes the hypoxia-induced depression of currents normally observed in these cells.

View larger version (24K): [in this window] [in a new window]   Fig. 3.   Pharmacological manipulation of K+ currents in H146 cells. Mean (± S.E.), normalized time series plots of K+ current amplitudes evoked at 0 mV by the ramp protocol (shown in Fig. 1A) demonstrating transient halothane reversibility of hypoxic inhibition (A) (n = 6), arachidonic acid blockade of hypoxic inhibition (B) (n = 9), and dithiothreitol insensitivity of the hypoxic suppression of K+ currents (C) (n = 6). Application of hypoxic perfusate and pharmacological agents is indicated by horizontal bars.

All K_2P channels except TASKs have a conserved cysteine in the P1-M2 extracellular linker (32), and it has been firmly established (at least for TWIK) that functional dimerization through the disulfide bridge formation at this residue is imperative for full channel activity (18). It follows, therefore, that treatment of cells with a potent reducing agent should perturb the function of all K_2P channels except that of TASKs. Fig. 3C demonstrates that although 1 mM DTT causes partial inhibition of the whole-cell K⁺ current, the hypoxia-evoked current suppression is not significantly altered (hypoxic inhibition = 26.7 ± 6.2% in the absence of DTT versus 31.3 ± 3.5% in the presence of DTT; n = 6, p > 0.5).

Proton Sensitivity Revisited: The Effect of External pH on O₂ Sensing-- The evidence presented above further reinforces our earlier suggestion that TASK is an O₂-sensitive K⁺ channel in these cells. However, our previous failure to demonstrate pH sensitivity of the K⁺ current may have been due, as in other channel types, to competition between Cd²⁺ and H⁺ at the pH-sensitive domain. The data in Fig. 4 address this possibility and show that, indeed, in the absence of external Cd²⁺, K⁺ currents are suppressed in pH 6.0 by 17.5 ± 5.8% (Fig. 6, A and B). Importantly, there was a high correlation between the pH-sensitive current and the O₂-sensitive current (Fig. 6C), suggesting that they are one and the same; at pH 7.4 the O₂-sensitive K⁺ current was 50.5 ± 15.6 pA, whereas lowering pH to 6.0 resulted in an 50% inhibition of the O₂-sensitive current to 25.7 ± 6.6 pA (Fig. 4C, n = 6, p < 0.05). Because the proton IC₅₀ of TASK3 is equivalent to pH values of between 6 and 6.5 (see, e.g. Ref. 33), this degree of inhibition is completely consistent with TASK3 as the O₂-sensitive current. In contrast, all investigators report that TASK1 is inhibited by 85-100% at pH 6.0 (14, 34-36).

View larger version (15K): [in this window] [in a new window]   Fig. 4.   Acidosis suppresses hypoxic inhibition of K+ currents in H146 cells. A, exemplar ramp-current traces recorded in the same cell under normoxic (~150 mm Hg) and hypoxic (15-25 mm Hg) conditions at pHo 7.4 and pHo 6.0, as indicated to the right of the records. Voltage protocol used to evoke these currents was as shown in Fig. 1A. B, exemplar time series plot of a cell under normoxic (~150 mm Hg) and hypoxic (15-25 mm Hg) conditions at pH 7.4 and at pH 6.0. Each point represents the current amplitude measured at 0 mV (taken from consecutive ramp depolarizations at 0.1 Hz, and the conditions were altered as indicated by the horizontal bars. C, a plot showing the correlation between the magnitude of the hypoxic response at pH 7.4 (x axis) and at pH 6.0 (y axis). Each data point (solid circles) was taken from paired experiments exemplified in B. The dotted lines indicate the no-effect and 50% inhibition levels; the latter represent the mean effect (solid square, with S.E. bars, taken from the six cells studied).

Antisense Transfection and Protein Knock-down: Fluorescence and Immunocytochemistry-- In order to verify and quantitate transfection efficiency of the oligodeoxynucleotides and specific protein knock-down, dual fluorescence studies were carried out. These showed that FITC-labeled antisense and missense oligodeoxynucleotides were incorporated with high efficiency. Morphometry on random low power fields (see Fig. 5A for exemplar fields) from two separate transfections revealed that missense incorporation was 100% (118 of 118; Fig. 5A, panel e), whereas antisense incorporation was found in 83% (76 of 87; Fig. 5A, panel i) of cells. Fig. 5A, panel a, shows that LipofectAMINE-only-treated cells had low FITC autofluorescence. The TRITC fluorescence micrographs show that hTASK-1 protein was detectable in the majority of cells treated only with LipofectAMINE (Fig. 5A, panel b) or missense probe (89%, 105 of 118; Fig. 5A, panel f). Most striking, however, was the dramatic reduction of TRITC fluorescence (hTASK1 antibody) in cells treated with antisense incorporation (18%, 16 of 87 cells showing detectable fluorescence; Fig. 5A, panel j). This is an underestimation of the knock-down effect of antisense probe because in the dual fluorescence micrographs (exemplified in Fig. 5A, panels c, g, and k), it is clear that almost all cells that demonstrated successful transfection were TRITC-negative. That is, only 6% (5 of 87) of antisense-treated cells demonstrated dual labeling compared with 89% of missense-treated cells. Finally, the specificity of the hTASK-1 antibody employed in these studies is supported by the almost complete lack of fluorescence when the antibody was applied after preadsorption with the epitope against which it was raised (Fig. 5A, panels d, h, and l). These observations from low power micrographs are more clearly illustrated in the high power images of Fig. 5B. In this exemplar series of images, it is apparent that cells successfully transfected with missense probe are still hTASK1-positive (Fig. 5B, panels d-f), whereas those that had been successfully antisense-transfected are all hTASK1-negative (Fig. 5B, panels g-i).

View larger version (47K): [in this window] [in a new window]   Fig. 5.   Cellular localization of antisense probe, missense probe, and hTASK-1 protein. A, low magnification images of cytospun H146 cells transfected with LipofectAMINE alone (a-d), missense probe (e-h), or antisense probe (i-l) to indicate the efficiency of probe incorporation and protein knock-down. The first column (a, e, and i) demonstrates efficiency of probe incorporation. The second column (b, f, and j) shows hTASK-1 immunoreactivity. The third column (c, g, and k) shows co-localization of probe and hTASK-1 protein. The fourth column (d, h, and l) shows nonspecific immunoreactivity in cells following a preadsorbtion step with the epitope used to raise the hTASK-1 antibody. Scale bar represents 40 µm and applies to all panels. B, exemplar high power images from LipofectAMINE-only-treated (a-c), missense-treated (d-f), or antisense oligodeoxynucleotide-treated (g-i) H146 cells. The first column (a, d, and g) shows FITC localization of probe, where applicable. The second column (b, e, and h) shows TRITC localization of anti hTASK-1 antibody. The third column (c, f, and i) shows dual fluorescence images and demonstrates that only antisense transfection resulted in specific hTASK-1 protein knock-down. The scale bar represents 10 µm and applies to all panels.

Response of K⁺ Currents to Acute Hypoxia following Successful Antisense Transfection and Protein Knock-down-- Capacitance measured in cells following 4-5-day antisense treatment was not significantly different (p > 0.1) from those following LipofectAMINE-only treatment or missense treatment (LipofectAMINE, 4.32 ± 0.36 pF, n = 11; antisense, 4.00 ± 0.32 pF, n = 12; missense, 3.92 ± 0.28, n = 5). In cells treated for 4-5 days with LipofectAMINE-only or missense probe, hypoxia elicited an inhibitory effect that was similar to that exemplified in Figs. 1-4 (Fig. 6, A, B, and D). In this series of experiments, a pO₂ of 15-25 mm Hg reversibly reduced mean outward K⁺ current amplitudes (measured at 0 mV from the step depolarization; see Fig. 1) in LipofectAMINE-treated cells from 130. 3 ± 30.8 to 102.5 ± 23.5 pA (n = 11), a significant (p < 0.005) reduction of 22.2 ± 3.3% (Fig. 6, A amd D). In missense-treated cells, there was a similar hypoxic inhibition from 100.4 ± 12.0 to 82.2 ± 11.2 pA (p < 0.005, n = 5), corresponding to a reduction of 19.5 ± 4.2% (Fig. 6, B and D). However, in antisense-treated cells, hypoxic inhibition was almost completely absent, with currents being reduced from 89.6 ± 19.6 to 88.6 ± 19.6 pA, a nonsignificant decrease (p > 0.3, n = 12) of less than 1.7 ± 2.5% (Fig. 4, C and D). Fig. 7, A-C, plots typical current-voltage relationships derived from the ramp voltage-clamp protocol (see Fig. 1). Fig. 6D shows the calculated hypoxia-sensitive current (((current in control + current after washout)/2) - current in hypoxia). For LipofectAMINE-only-treated cells (Fig. 7A) and missense-treated cells (Fig. 7B), hypoxic inhibition was apparent at voltages positive to -40 mV (see Fig. 7D). In stark contrast, hypoxia had no effect on currents at any test potential in antisense-treated cells (Fig. 7, C and D).

View larger version (28K): [in this window] [in a new window]   Fig. 6.   The effect of antisense and missense oligodeoxynucleotide treatment on the time course of hypoxic inhibition. Mean time courses of the effect of acute hypoxia (15-25 mm Hg, applied for the period indicated by the horizontal bar) on cells treated only with LipofectAMINE (A) (n = 11), on cells treated with missense oligodeoxynucleotide (B) (n = 5), and on cells treated with antisense oligodeoxynucleotide (C) (n = 12). The bar graph shown in D plots the mean hypoxic inhibition in Lipofect- AMINE-only-treated (control), hTASK antisense-treated, or missense oligodeoxynucleotide-treated cells, as indicated.

View larger version (23K): [in this window] [in a new window]   Fig. 7.   The effect of antisense and missense oligodeoxynucleotide treatment on current-voltage relationships during hypoxic inhibition. I-V relationships derived from the voltage ramp before (control), during (hypoxia), and following (wash) acute hypoxic inhibition in an exemplar cell treated only with LipofectAMINE (A), with missense oligodeoxynucleotide (B), or with antisense oligodeoxynucleotide (C). Also shown in (A-C) are difference currents that were calculated by subtracting evoked currents in hypoxia from the mean of the control and wash traces. These hypoxia-sensitive (difference) currents are superimposed as I-V relationships in D.

Zn²⁺ as Final Discriminator-- The data presented thus far cannot conclusively discriminate between hTASK1 and hTASK3. In the final series of experiments, following molecular confirmation of the involvement of one or both of these human K_2P channels, we employed 100 µM Zn²⁺ as a method of distinguishing between hTASK1 and hTASK3. Zn²⁺ blocks both channels, but because the concentration-response curves of the two recombinant channels are an order of magnitude apart, 100 µM would be expected to cause significant inhibition of the hTASK1 current (37) while not significantly affecting hTASK3 (33). Fig. 8 shows that although 100 µM Zn²⁺ blocked about 20% of the K⁺ current (Fig. 8, A and B), it was an ineffective inhibitor of the hypoxic K⁺ current suppression because hypoxia evoked a 23.1 ± 6.2% inhibition in the absence of Zn²⁺ and 28.1 ± 9.1% in the absence of Zn²⁺ (Fig. 8C), thus suggesting that hTASK3 is the more likely of the K⁺ channels to be O₂-sensitive in these cells.

View larger version (15K): [in this window] [in a new window]   Fig. 8.   Hypoxic inhibition of K+ currents in H146 cells is not prevented by Zn2+. A, typical ramp-current traces recorded in the same cell under normoxic (~150 mm Hg) and hypoxic (15-25 mm Hg) conditions in the presence and absence of 100 µM Zn2+ , as indicated to the right of the records. The voltage protocol used to evoke these currents was as shown in Fig. 1A. B, representative time series plot of a cell under normoxic (~150 mm Hg) and hypoxic (15-25 mm Hg) conditions in the absence and presence of 100 µM Zn2+. Each point represents the current amplitude measured at 0 mV (taken from consecutive ramp depolarizations at 0.1 Hz), and the conditions were altered as indicated by the horizontal bars. C, a plot showing the correlation between the magnitude of the hypoxic response in the absence (x axis) and presence (y axis) of 100 µM Zn2+. Each data point (solid circles) was taken from paired experiments exemplified in B. The dotted line indicates the no-effect level; the mean effect is shown by the solid square (with S.E. bars, taken from the eight cells studied).

	DISCUSSION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

The data presented herein demonstrate directly the molecular identity of the oxygen-sensitive ion channel in the chemosensing cell line H146. Relative TEA insensitivity (Fig. 1) coupled to an ability to influence resting membrane potential (8) is a characteristic exclusive to K_2P channels, and we have demonstrated the mRNA encoding six members of this K⁺ channel family in these chemosensing cells (Fig. 2). Activation by halothane (Fig. 3A), pH dependence (Fig. 4), and insensitivity to DTT (Fig. 3C) effectively rule out the involvement of all K_2P channels other than the subfamily TASK (32) and blockade by arachidonic acid (Fig. 3B) points firmly toward hTASK1 or hTASK3 as the O₂-sensitive channel in H146 cells. Although in other systems there have been significant steps taken to identify the O₂-sensitive channel in that cell/tissue (12, 38), direct evidence that disrupting channel transcription/translation leads to loss of loss of oxygen sensitivity has not, until now, been presented. Here, we have shown that antisense knock-down of hTASK1 (and presumably hTASK3) results in a complete lack of O₂ sensing in this model cell line. This effect is selective, because missense treatment was without effect, disrupting neither channel expression nor functional O₂ sensitivity. This is the clearest evidence to date that hTASKs are of central importance in the chemotransductive pathway linking environmental O₂ levels to membrane potential, Ca²⁺ influx, and hence neurosecretion in this model NEB cell line. In this regard, our findings compare well with recent, albeit indirect, evidence in the carotid body arterial chemoreceptor glomus cell, where TASK1 has been shown to be present and where the electrophysiology suggests that TASK1 underlies a component of the oxygen-sensitive K⁺ current (12). This class of voltage-insensitive K⁺ channel, which exerts important influences on membrane potential and so on electrical excitability, is therefore of fundamental importance in O₂ sensing cells in general and, owing to its widespread distribution (14), is likely to be similarly important in a plethora of other cell types.

Our choice of missense and antisense probes, which was based on our PCR and gene sequence information, would appear to be appropriate. This assumption is based on the fluorescence data presented in Fig. 5 and corroborated by the electrophysiological data in Figs. 6 and 7. Thus, we have demonstrated that treatment of cells with an 18-mer antisense probe directed across the atg start codon of hTASK1 and hTASK3 results in robust, almost complete knockout of hTASK1 protein expression, which is mirrored by loss of O₂ sensitivity. That this effect is specifically due to down-regulation of antisense-mediated protein transcription/translation is evidenced by the inability of the missense probe to affect either immunoreactivity or O₂ sensitivity. These data also highlight two important technical issues. First, because LipofectAMINE-only-treated cells behaved in a manner comparable to both missense-treated (see Figs. 6 and 7) and untreated H146 cells, it appears that in this system it may be more expeditious to employ untreated cells as a suitable control. Second, optimized treatment with small oligodeoxynucleotides using LipofectAMINE is both nontoxic and an extraordinarily efficient procedure for ion channel knock-down/knockout (see Fig. 5). Interestingly, protein knock-down with the antisense probe was successful in 89% of cells (Fig. 5). This finding corresponds well with the hypoxic responses in these cells (Fig. 6). Although the mean hypoxic inhibition was negligible (approximately 2%), 1 of the 12 cells tested (and included in our analyses) responded in a manner comparable to LipofectAMINE or missense-treated cells.

Experimentally, it is unfortunate that hTASK1 and hTASK3 show such high sequence identity. Thus, design of an antisense probe that could distinguish between these two channels and that could be directed across the translation start site was impossible. Furthermore, there is no antibody available to hTASK3. Therefore, we assumed that hTASK1 immunoreactivity after hTASK1/hTASK3 antisense treatment would reflect protein knock-down of both of these channels. This assumption appears to hold true; Fig. 8 shows directly that the hypoxia-sensitive current (which is lost with antisense treatment) is unlikely to be hTASK1 because it is completely insensitive to a discriminating concentration of extracellular Zn²⁺. Previous studies have reported that at a concentration of 100 µM Zn²⁺ only blocks ~5% of TASK3 (33), yet TASK1 shows far greater sensitivity (12, 35).

The degree of inhibition of the O₂-sensitive K⁺ current by pH 6.0 reported here in H146 cells (~50%) appears to be less than that reported for TASK channels by others. There is good agreement that TASK1 is severely inhibited at pH 6.0 (by 85-100%) (14, 34-36). By contrast, the responses of TASK3 to such a decrease in pH are usually less yet more variable, ranging from 96% (33) to as little as 50% (28, 40). Our data, showing 50% inhibition of the O₂-sensitive K⁺ current, strongly suggest that the underlying channel resembles TASK3 rather than TASK1.

Although we have accumulated a pharmacological profile for the O₂-sensitive K⁺ channel in H146 cells that suggests it to be hTASK3, there is a minor discrepancy in the degree of blockade by 100 µM quinidine that we have previously reported (79% (7)). As with the considerations of pH and the Zn²⁺ regulation outlined above, there is little convergence between laboratories or species on the effect of quinidine on hTASK. However, it is important to note that hTASK1 is blocked by less than 20% (100 µM quinidine (14)), whereas the same concentration evokes greater inhibition of hTASK3 (42% (28)) and rTASK3 (37% (33)), i.e. quinidine is a more effective blocker of TASK3 than TASK1. Our previous data show 100 µM quinidine to inhibit by 79% (7), a value more consistent with TASK3 than TASK1. It is important to note that our data cannot rule out the possibility that the O₂-sensitive current is carried by a heterodimer of hTASK1 and hTASK3, a possibility that may explain some of the mixed pharmacology reported here and previously. Also worthy of consideration is the possible presence of TASK5 (KT3.3), because the sequence for this putative channel shows significant homology to TASK1 and TASK3. However, our antisense probe only shares 12 of the 18 bases, a mismatch unlikely to promote good annealing. Furthermore, there are no functional data available on this candidate member of the TASK family.

In conclusion, although we have no direct evidence that the same channel underlies the hypoxic response in native NEB cells, the available comparative pharmacology suggests this to be the case. O₂-sensitive currents in both NEB and H146 cells are 4-aminopyridine-insensitive, weakly TEA-sensitive, blockable by quinidine, and have a significant calcium-independent component (7, 8, 39, 41). Thus, the present study provides direct functional evidence, through the use of pharmacology and an antisense knock-down/knockout approach, that hTASK channels are oxygen-sensitive in a native cellular system. Furthermore, hTASK1 and hTASK3 are clear candidate channels in the chemotransduction pathway in other oxygen sensing tissues, and it is tempting to speculate that their expression in diverse tissues may represent a unifying oxygen-sensitive effector protein family.

	ACKNOWLEDGEMENTS

We thank Prof. N. Buckley and Dr. J. Deuchars for helpful discussion and advice concerning antisense design and immunocytochemistry, respectively.

	FOOTNOTES

^* This work was funded by the British Heart Foundation and the Wellcome Trust.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

^¶ To whom correspondence should be addressed. Tel.: 44-113-233-4236; Fax: 44-113-233-4228; E-mail: p.z.kemp@leeds.ac.uk.

Published, JBC Papers in Press, May 8, 2001, DOI 10.1074/jbc.M010357200

	ABBREVIATIONS

The abbreviations used are: pO₂, partial pressure of oxygen (mm Hg); DTT, dithiothreitol; FITC, fluorescein isothiocyanate; PBS, phosphate buffered saline; RT, reverse transcription; PCR, polymerase chain reaction; TEA, tetraethylammonium; TRITC, tetramethylrhodamine isothiocyanate; NEB, neuroepithelial body.

	REFERENCES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				S. Bittner, S. G. Meuth, K. Gobel, N. Melzer, A. M. Herrmann, O. J. Simon, A. Weishaupt, T. Budde, D. A. Bayliss, M. Bendszus, et al. TASK1 modulates inflammation and neurodegeneration in autoimmune inflammation of the central nervous system Brain, July 1, 2009; (2009) awp163v1. [Abstract] [Full Text] [PDF]

				D. Adriaensen, I. Brouns, I. Pintelon, I. De Proost, and J.-P. Timmermans Evidence for a role of neuroepithelial bodies as complex airway sensors: comparison with smooth muscle-associated airway receptors J Appl Physiol, September 1, 2006; 101(3): 960 - 970. [Abstract] [Full Text] [PDF]

				P. J. Kemp Detecting acute changes in oxygen: will the real sensor please stand up? Exp Physiol, September 1, 2006; 91(5): 829 - 834. [Abstract] [Full Text] [PDF]

				A. Roch, V. Shlyonsky, A. Goolaerts, F. Mies, and S. Sariban-Sohraby Halothane Directly Modifies Na+ and K+ Channel Activities in Cultured Human Alveolar Epithelial Cells Mol. Pharmacol., May 1, 2006; 69(5): 1755 - 1762. [Abstract] [Full Text] [PDF]

				B. Musset, S. G. Meuth, G. X. Liu, C. Derst, S. Wegner, H.-C. Pape, T. Budde, R. Preisig-Muller, and J. Daut Effects of divalent cations and spermine on the K+ channel TASK-3 and on the outward current in thalamic neurons J. Physiol., May 1, 2006; 572(3): 639 - 657. [Abstract] [Full Text] [PDF]

				Y. Yamamoto and K. Taniguchi Expression of Tandem P Domain K+ Channel, TREK-1, in the Rat Carotid Body J. Histochem. Cytochem., April 1, 2006; 54(4): 467 - 472. [Abstract] [Full Text] [PDF]

				X. Bai, G. J Bugg, S. L Greenwood, J. D Glazier, C. P Sibley, P. N Baker, M. J Taggart, and G. K Fyfe Expression of TASK and TREK, two-pore domain K+ channels, in human myometrium Reproduction, April 1, 2005; 129(4): 525 - 530. [Abstract] [Full Text] [PDF]

				R. W. Putnam, J. A. Filosa, and N. A. Ritucci Cellular mechanisms involved in CO2 and acid signaling in chemosensitive neurons Am J Physiol Cell Physiol, December 1, 2004; 287(6): C1493 - C1526. [Abstract] [Full Text] [PDF]

				M. G Jonz, I. M Fearon, and C. A Nurse Neuroepithelial oxygen chemoreceptors of the zebrafish gill J. Physiol., November 1, 2004; 560(3): 737 - 752. [Abstract] [Full Text] [PDF]

				C. E Clarke, E. L Veale, P. J Green, H. J Meadows, and A. Mathie Selective block of the human 2-P domain potassium channel, TASK-3, and the native leak potassium current, IKSO, by zinc J. Physiol., October 1, 2004; 560(1): 51 - 62. [Abstract] [Full Text] [PDF]

				M. T. Perez-Garcia, O. Colinas, E. Miguel-Velado, A. Moreno-Dominguez, and J. R. Lopez-Lopez Characterization of the Kv channels of mouse carotid body chemoreceptor cells and their role in oxygen sensing J. Physiol., June 1, 2004; 557(2): 457 - 471. [Abstract] [Full Text] [PDF]

				G. Czirjak, Z. E. Toth, and P. Enyedi The Two-pore Domain K+ Channel, TRESK, Is Activated by the Cytoplasmic Calcium Signal through Calcineurin J. Biol. Chem., April 30, 2004; 279(18): 18550 - 18558. [Abstract] [Full Text] [PDF]

				J. Lopez-Barneo, R. del Toro, K. L. Levitsky, M. D. Chiara, and P. Ortega-Saenz Regulation of oxygen sensing by ion channels J Appl Physiol, March 1, 2004; 96(3): 1187 - 1195. [Abstract] [Full Text] [PDF]

				R. P. Johnson, I. M. O'Kelly, and I. M. Fearon System-specific O2 sensitivity of the tandem pore domain K+ channel TASK-1 Am J Physiol Cell Physiol, February 1, 2004; 286(2): C391 - C397. [Abstract] [Full Text]

				J. A. Neubauer and J. Sunderram Oxygen-sensing neurons in the central nervous system J Appl Physiol, January 1, 2004; 96(1): 367 - 374. [Abstract] [Full Text] [PDF]

				J. Van Genechten, I. Brouns, G. Burnstock, J.-P. Timmermans, and D. Adriaensen Quantification of Neuroepithelial Bodies and Their Innervation in Fawn-Hooded and Wistar Rat Lungs Am. J. Respir. Cell Mol. Biol., January 1, 2004; 30(1): 20 - 30. [Abstract] [Full Text] [PDF]

				D. Kang, J. Han, E. M. Talley, D. A. Bayliss, and D. Kim Functional expression of TASK-1/TASK-3 heteromers in cerebellar granule cells J. Physiol., January 1, 2004; 554(1): 64 - 77. [Abstract] [Full Text] [PDF]

				M. E. Hartness, S. P. Brazier, C. Peers, A. N. Bateson, M. L. J. Ashford, and P. J. Kemp Post-transcriptional Control of Human maxiK Potassium Channel Activity and Acute Oxygen Sensitivity by Chronic Hypoxia J. Biol. Chem., December 19, 2003; 278(51): 51422 - 51432. [Abstract] [Full Text] [PDF]

				A.M. Gurney, O.N. Osipenko, D. MacMillan, K.M. McFarlane, R.J. Tate, and F.E.J. Kempsill Two-Pore Domain K Channel, TASK-1, in Pulmonary Artery Smooth Muscle Cells Circ. Res., November 14, 2003; 93(10): 957 - 964. [Abstract] [Full Text] [PDF]

				I. Lauritzen, M. Zanzouri, E. Honore, F. Duprat, M. U. Ehrengruber, M. Lazdunski, and A. J. Patel K+-dependent Cerebellar Granule Neuron Apoptosis: ROLE OF TASK LEAK K+ CHANNELS J. Biol. Chem., August 22, 2003; 278(34): 32068 - 32076. [Abstract] [Full Text] [PDF]

				D. A. Bayliss, J. E. Sirois, and E. M. Talley The TASK Family: Two-Pore Domain Background K+ Channels Mol. Interv., June 1, 2003; 3(4): 205 - 219. [Abstract] [Full Text] [PDF]

				V. A Campanucci, I. M Fearon, and C. A Nurse A novel O2-sensing mechanism in rat glossopharyngeal neurones mediated by a halothane-inhibitable background K+ conductance J. Physiol., May 1, 2003; 548(3): 731 - 743. [Abstract] [Full Text] [PDF]

				P Miller, P J Kemp, A Lewis, C G Chapman, H J Meadows, and C Peers Acute hypoxia occludes hTREK-1 modulation: re-evaluation of the potential role of tandem P domain K+ channels in central neuroprotection J. Physiol., April 1, 2003; 548(1): 31 - 37. [Abstract] [Full Text] [PDF]

				I. Brouns, J. Van Genechten, H. Hayashi, M. Gajda, T. Gomi, G. Burnstock, J.-P. Timmermans, and D. Adriaensen Dual Sensory Innervation of Pulmonary Neuroepithelial Bodies Am. J. Respir. Cell Mol. Biol., March 1, 2003; 28(3): 275 - 285. [Abstract] [Full Text] [PDF]

				G. Czirjak and P. Enyedi Ruthenium Red Inhibits TASK-3 Potassium Channel by Interconnecting Glutamate 70 of the Two Subunits Mol. Pharmacol., March 1, 2003; 63(3): 646 - 652. [Abstract] [Full Text] [PDF]

				P. J. Kemp, A. Lewis, M. E. Hartness, G. J. Searle, P. Miller, I. O'Kelly, and C. Peers Airway Chemotransduction: From Oxygen Sensor to Cellular Effector Am. J. Respir. Crit. Care Med., December 15, 2002; 166(12): S17 - 24. [Abstract] [Full Text] [PDF]

				L. J Teppema, D. Nieuwenhuijs, E. Sarton, R. Romberg, C. N Olievier, D. S Ward, and A. Dahan Antioxidants prevent depression of the acute hypoxic ventilatory response by subanaesthetic halothane in men J. Physiol., November 1, 2002; 544(3): 931 - 938. [Abstract] [Full Text] [PDF]

				L. D. Plant, P. J. Kemp, C. Peers, Z. Henderson, and H. A. Pearson Hypoxic Depolarization of Cerebellar Granule Neurons by Specific Inhibition of TASK-1 Stroke, September 1, 2002; 33(9): 2324 - 2328. [Abstract] [Full Text] [PDF]

				A Lewis, C Peers, M L J Ashford, and P J Kemp Hypoxia inhibits human recombinant large conductance, Ca2+-activated K+ (maxi-K) channels by a mechanism which is membrane delimited and Ca2+ sensitive J. Physiol., May 1, 2002; 540(3): 771 - 780. [Abstract] [Full Text] [PDF]

				A. Lewis, C. Peers, M.L.J. Ashford, and P. J. Kemp Hypoxia inhibits human recombinant large conductance, Ca2+-activated K+ (maxi-K) channels by a mechanism which is membrane delimited and Ca2+ sensitive J. Physiol., March 8, 2002; (2002) 200101388. [Abstract] [PDF]

This Article Abstract Full Text (PDF) All Versions of this Article: 276/28/26499    most recent M010357200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hartness, M. E. Articles by Kemp, P. J. Search for Related Content PubMed PubMed Citation Articles by Hartness, M. E. Articles by Kemp, P. J. Social Bookmarking                      What's this?